BFLY

Prominent POCUS thought leader joins to advance clinical strategy and further Butterfly's mission to democratize ultrasound worldwide. Butterfly Network (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Arun Nagdev, MD as Chief Medical Officer – Point-of-Care Ultrasound (POCUS). In this role, Dr. Nagdev will lead the global medical strategy for the Company's core POCUS business, advancing clinical product validation, strengthening customer engagement, and supporting regulatory and clinical development efforts. Dr. Nagdev brings more than 20 years of experience advancing POCUS adoption, educ

4 - Butterfly Network, Inc. (0001804176) (Issuer)

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report first quarter 2026 financial results on Thursday, April 30, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast before the market opens on April 30 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations website at Events & Presentations.

The new AI-powered tool determines how far along a pregnancy is in minutes—providing critical information to guide timely care and help reduce maternal and fetal mortality worldwide. Butterfly Network, Inc. ("Butterfly," "the Company") (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for a fully automated Gestational Age (GA) Tool integrated into its handheld ultrasound solution. This marks the first FDA-cleared blind-sweep ultrasound AI tool for estimating gestational age. This press release features multimedia. View the full release

SCHEDULE 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

SCHEDULE 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

Chirp Microsystems Co-Founder Joins Butterfly to Advance its Ultrasound-on-Chip™ Platform Strategy Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of David Horsley, Ph.D. as Senior Vice President of Innovation – Butterfly Embedded™ to scale its Ultrasound-on-Chip™ co-development and licensing initiative. In this role, Dr. Horsley will lead strategy and go-to-market for Butterfly Embedded, overseeing new product development, partnerships, and commercialization efforts. Butterfly Embedded is focused on extending the reach of the company's proprietary semic

4 - Butterfly Network, Inc. (0001804176) (Issuer)

144 - Butterfly Network, Inc. (0001804176) (Subject)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

144 - Butterfly Network, Inc. (0001804176) (Subject)

144 - Butterfly Network, Inc. (0001804176) (Subject)

Issued on behalf of VentriPoint Diagnostics Ltd.VANCOUVER, BC, March 3, 2026 /CNW/ -- USANewsGroup.com News Commentary -- AI is making its way through the halls of our entire medical system, and the implementation is accelerating at a great pace. The AI medical imaging market is projected to hit nearly $20 billion by 2033, growing at a 34.7% CAGR[1]. Echocardiography alone is forecast to grow to $2.64 billion by 2030 as hospitals demand cardiac platforms that prove economic value alongside clinical accuracy[2]. Companies like VentriPoint Diagnostics (TSXV:VPT) (OTCPK: VPTDF), Butterfly Network (NYSE:BFLY), Tempus AI (NASDAQ:TEM), RadNet (NASDAQ:RDNT), and GE HealthCare (NASDAQ:GEHC) are conv

4 - Butterfly Network, Inc. (0001804176) (Issuer)

S-8 - Butterfly Network, Inc. (0001804176) (Filer)

10-K - Butterfly Network, Inc. (0001804176) (Filer)

8-K - Butterfly Network, Inc. (0001804176) (Filer)

Delivered Record Annual and Quarterly Revenue Reported quarterly record Revenue of $31.5 million in Q4, representing 41% YoY growth Generated positive net cash flow of $6.3 million in Q4 and lowest annual cash usage in company history Midjourney partnership contributed $6.8 million of revenue in Q4, advancing Butterfly Embedded™ platform strategy Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced financial results for the fourth quarter and year ended December 31, 2025, and provided a business update. Joseph DeVivo, Butterfly's Presiden

SCHEDULE 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced that it will participate at the TD Cowen 46th Annual Health Care Conference in Boston on March 3, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, EVP, Chief Financial Officer; and Megan Carlson, SVP, Accounting & Finance – Chief Accounting Officer, will present and host one-on-one investor meetings. The company presentation will occur at 11:50 AM ET on March 3. A webcast of the presentation will be available in the Events & Presentations section of the Butterfly investor website (h